Memantine for PDD or DLB

Underwriting Quick Notes:

  • PDD = Parkinson’s Disease Dementia
  • DLB = Dementia with Lewy Bodies
  • Memantine = Namenda

Memantine for patients with Parkinson’s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial : The Lancet Neurology

Memantine seems to improve global clinical status and behavioural symptoms of patients with mild to moderate DLB, and might be an option for treatment of these patients.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s